← FDA Drug Approvals (Drugs@FDA)
IBUPROFEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2022-05-27
Drug application
- FDA Application #
ANDA215311- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBUPROFEN
- Generic name
- IBUPROFEN
- Active ingredients
- IBUPROFEN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- STRIDES PHARMA
- Manufacturer
- Strides Pharma Science Limited
- First approval
- 2022-05-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown